Gleason Score Discrepancies Between Needle Biopsies and Radical Prostatectomy Specimens in an African Men: Clinical Implication
- Authors
-
-
Abdellatif Janane
Department of Urology, Universitary Military Hospital Mohamed V. Rabat, Morocco -
Fouad Hajji
Department of Urology, Universitary Military Hospital Mohamed V. Rabat, Morocco -
Youssef Dakkak
Department of Urology, Universitary Military Hospital Mohamed V. Rabat, Morocco -
Mohamed Ghadouane
Department of Urology, Universitary Military Hospital Mohamed V. Rabat, Morocco -
Ahmed Ameur
Department of Urology, Universitary Military Hospital Mohamed V. Rabat, Morocco -
Mohamed Abbar
Department of Urology, Universitary Military Hospital Mohamed V. Rabat, Morocco -
Abderhman Albouzidi
Department of Pathology, Universitary Military Hospital Mohamed V. Medical University Med V. Rabat, Medical Faculty Mohamed V. Rabat, Morocco
-
- Keywords:
- Prostate adenocarcinoma, needle biopsy, radical prostatectomy, Gleason score correlation, prognostic significance.
- Abstract
-
Objective:Gleason scores, as determined by 18-gauge core needle biopsies (NB), were compared with both Gleason scores and the pathological staging of corresponding radical prostatectomy( RP) specimens. The goal was to evaluate the clinical implication and the prognostic impact of these discrepancies.
Methods: Records of 234 consecutive patients undergoing a radical retro pubic prostatectomy between 2001 and 2012 were reviewed. In total, all our patients were enrolled, al1 of whom had been diagnosed with adenocarcinoma by transrectal needle biopsies using an 18-gauge automated spring-loaded biopsy gun.
Results: Grading errors were greatest with wel1-differentiated tumors. The accuracy was 18 (23%) for Gleason scores of 2-4 on needle biopsy. Of the 108 evaluable patients with Gleason scores of 5-7 on needle biopsy, 84 (78%) were graded correctly. All of the Gleason scores of 8-10 on needle biopsy were graded correctly. 54 of 162 patients (33%), with a biopsy Gleason score of < 7 had their cancer upgraded to above 7. Tumors in 18 patients (60%) with both a Gleason score < 7 on the needle biopsy and a Gleason score of 7 for the prostatectomy specimen were confined to the prostate.
Conclusion: The potential for grading errors is greatest with well-differentiated tumors and in patients with a Gleason score of < 7 on the needle biopsy. Predictions using Gleason scores are sufficiently accurate to warrant its use with all needle biopsies, recognizing that the potential for grading errors is greatest with well-differentiated tumors.
- References
-
Cookson MS, Fleshner NE, Soloway SM, Fair WR. Corre1ation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 1997; 157: 559-62. http://dx.doi.org/10.1016/S0022-5347(01)65201-7
Gonzalgo ML, Bastian PJ, Mangold LA, et al. Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate. Urology 2006; 49: 820-26.
Makhlouf AA, Krupski TL, Kunkle D, Theodorescu D. The effect of sampling more cores on the predictive accuracy of pathological grade and tumor distrubition in the prostate biopsy. BJU Int 2004; 93: 271-74. http://dx.doi.org/10.1111/j.1464-410X.2004.04600.x
King CR, Mc Neal JE, Gill H, Presti Jr JC. Extended prostate biopsy scheme improves reliability of Gleason grading: implication of radiotherapy patients. Int J Radiat Oncol Biol Phys 2004; 59: 386-61. http://dx.doi.org/10.1016/j.ijrobp.2003.10.014
Koksal T, Ozcan F, Kadiog1u TC, Esen T. Klcaslan J, Tunc M. Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens. Eur Urol 2000; 37: 670-4. http://dx.doi.org/10.1159/000020216
Chun FK-H, Steuber T, Erbersdobler A. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006; 49: 820-26. http://dx.doi.org/10.1016/j.eururo.2005.11.007
King CR. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int J cancer 2000. http://dx.doi.org/10.1002/1097-0215(20001220)90:6<305::AID-IJC1>3.0.CO;2-U
Epstein JI, Allsbrook Jr WC, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of prostatic carcinoma. Am J Surg Pathol 2005; 29: 1228-42. http://dx.doi.org/10.1097/01.pas.0000173646.99337.b1
Mûntener M, Epstein JI, Hernandez DJ, Gonzalgo ML, et al. Prognostic significance of Gleason Score discrepancies between needle biopsy and radical prostatectomy. Eur Urol 2008; 53: 767-76. http://dx.doi.org/10.1016/j.eururo.2007.11.016
Stephen A, Boorjian R, Jeffrey Karnes R, et al. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol 2009; 181: 95-104. http://dx.doi.org/10.1016/j.juro.2008.09.016
Rauf Taner D, Asken Erog L, Sahen A. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens Urol Oncol 2007; 25: 276-82.
Yang CW, Lin TP, Huang YH. Does extended prostate needle biopsy improve the concordance of Gleason score between biopsy and prostatectomy in the Taiwanese population? J Chin Med Ass 2012; 75: 97-101. http://dx.doi.org/10.1016/j.jcma.2012.02.001
Davies JD, Aghazadeh MA, Phillips S, Salem S. Prostate size as a predictor of Gleason upgrading in patients with low risk prostate cancer. J Urol 2011; 186: 2221-27. http://dx.doi.org/10.1016/j.juro.2011.07.104
Audenet F, Comperat E, Seringe E, et al. Patient risk stratification using Gleason concordance and upgrading among men with prostate biopsy Gleason score 6 or 7. Urol Oncol 2011; 29: 602-607. http://dx.doi.org/10.1016/j.urolonc.2009.09.011
Isariyawongse BK, Sun L, Banez LL, Robertson C, et al. Significant discrepancies between biopsic and pathologic Gleason sums in prostate cancer. The predictive role of Age and prostate specific antigen. Urology 2008; 72: 882-86. http://dx.doi.org/10.1016/j.urology.2008.02.021
Kuroiwa K, Shiraishi T, Naito S. Gleason score correlation between biopsy and prostatectomy specimen and prediction of high grade Gleason patterns: significance of central pathologic review. Urology 2011; 77: 407-11. http://dx.doi.org/10.1016/j.urology.2010.05.030
Gershman B, Dahi DM, Olumi AF, et al. Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol 2011; 28: 11-16.
- Downloads
- Published
- 2013-08-28
- Issue
- Vol. 2 No. 3 (2013)
- Section
- Articles
How to Cite
Similar Articles
- Mireia Gil-Raga, Javier Garde-Noguera, Advanced Colorectal Cancer , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- B. Raggiunti, A. Franchi, V. Congedo, S. Filipponi, G. Fiore, G. Raggiunti, D. Tina, A. Mongia, A. Rufo, F.A. Ruggieri , D. Di Michele , Mixed Medullary Papillary Thyroid Carcinoma in Hyperfunctioning Hot Nodule: A Case Report and Review of the Literature , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Paola Castro-Garcia, Carmen Gil-Gas, Paloma Honrubia-Gómez, Carmen Belen Alvarez-Simón, Jesús-José Ferré-Fernández, Francisco Sánchez-Sánchez, Jose Luis Sánchez-Sánchez, Jose Mª Garcia-Bueno, Sebastiá Sabater, Guadalupe Aparicio, Luis Miguel Antón-Aparicio, Carmen Ramírez-Castillejo, C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Bülent Özgönenel, Öner Özdemir, Melike Özgönenel,, Ronald Thomas, Steven Buck , Süreyya Savasan , The Effect of Pretreatment with Chemotherapeutic Drugs on the Susceptibility to Lymphokine Activated CD8+ T Lymphocyte-Mediated Cytotoxicity in CMK Leukemia Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Martin Czejka, Ernst Ulsperger, Heinz Schnait, Tamara Brumnik, Joerg Schierholz, Philipp Buchner, Richard Greil , Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Kazuya Kuraoka, Kiyomi Taniyama, Miho Tanaka, Yukari Nakagawa, Naoko Yasumura, Tamaki Toda, Mikie Shitaune, Akihisa Saito, Junichi Sakane, Yoko Kodama, Toshinao Nishimura, Nao Morii, Hirotoshi Takahashi , Hiroyasu Yamashiro , Auto-Analysis for Ki-67 Indices of Breast Cancer Using Specified Computer Software and a Virtual Microscopy , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Alberto Muñoz, Eider Azkona, Estíbaliz Iza, Eluska Iruarrizaga, Abigail Ruiz de Lobera, Itziar Rubio, Joan Manel Mañé, Sergio Carrera, Inés Marrodán Ciordia , Guillermo López-Vivanco , Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- T.K. Kulkarni, A. Banerjee, N. Banerjee, J. Cuffee, S. Newell, E. Armstrong, S.N. Deloatch, J. Jong Park, A.H. El-Hashash, S. Bhattacharya, H. Banerjee, An Investigation to Study Morphology, Nanomechanical Attributes, Transcriptomics, and Proteomics of Tumor Associated Macrophages Derived Extracellular Vesicles in the Tumor Microenvironment , Journal of Analytical Oncology: Vol. 15 (2026)
- Martin Balog, Ulrich Lang , Günther Winde , Buschke Löwenstein Tumor of the Right Lower Abdominal Wall: Case Report and Review of the Literature , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- A. Clare Berry, Adrian Charles, Nikolajs Zeps, D. Mark Cregan, Frank Arfuso , Arun Dharmarajan , Expression Profile of Wnt/β-Catenin Signalling Molecules and the Wnt Antagonist Secreted Frizzled-Related Protein 4 in Apoptosis in Breast Cancer Tissue Micro-Arrays , Journal of Analytical Oncology: Vol. 3 No. 4 (2014)
You may also start an advanced similarity search for this article.